- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Inhibitor Therapeutics Inc (INTI)
Inhibitor Therapeutics Inc stock price live, this page displays OTC INTI stock exchange data. View the INTI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Inhibitor Therapeutics Inc real time stock price chart below.
What Is the Inhibitor Therapeutics Inc Stock Price Today?
The Inhibitor Therapeutics Inc stock price today is 0.0470.
What Is the Stock Symbol for Inhibitor Therapeutics Inc?
The stock symbol for Inhibitor Therapeutics Inc is ""INTI.""
What Stock Exchange Does Inhibitor Therapeutics Inc Trade On?
Inhibitor Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Inhibitor Therapeutics Inc a Good Stock to Buy?
Determining whether Inhibitor Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INTI quote. (ISIN: US45720M1053)
What Is the Inhibitor Therapeutics Inc Stock Price Today?
The Inhibitor Therapeutics Inc stock price today is 0.0470.
What Is the Stock Symbol for Inhibitor Therapeutics Inc?
The stock symbol for Inhibitor Therapeutics Inc is ""INTI.""
What Stock Exchange Does Inhibitor Therapeutics Inc Trade On?
Inhibitor Therapeutics Inc is listed and trades on the OTC Markets stock exchange.
Is Inhibitor Therapeutics Inc a Good Stock to Buy?
Determining whether Inhibitor Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the INTI quote. (ISIN: US45720M1053)
OTC Markets
Currency in USD
0.0470
-0.0049(-9.44%)
Closed·
Fair Value
An estimate of a Inhibitor Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0425
0.0490
52 wk Range
0.0338
0.0988
INTI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
INTI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Inhibitor Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.04250.0490
52 wk Range
0.03380.0988
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INTI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Inhibitor Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell
Inhibitor Therapeutics Inc Company Profile
Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. It engages in the development of therapies for prostate and lung cancer utilizing itraconazole; and conducted a positive Phase 2b clinical trial of SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics, Inc. in August 2019. Inhibitor Therapeutics, Inc. was founded in 1992 and is based in Tampa, Florida.
Compare INTI to Peers and Sector
Metrics to compare | INTI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINTIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.5x | −3.3x | −0.5x | |
PEG Ratio | 0.71 | 0.01 | 0.00 | |
Price/Book | 6.0x | 2.5x | 2.6x | |
Price / LTM Sales | - | 9.2x | 3.3x | |
Upside (Analyst Target) | - | 194.7% | 43.4% | |
Fair Value Upside | Unlock | 4.9% | 7.1% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Inhibitor Therapeutics Trade On?
Inhibitor Therapeutics is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Inhibitor Therapeutics?
The stock symbol for Inhibitor Therapeutics is "INTI."
What Is the Inhibitor Therapeutics Market Cap?
As of today, Inhibitor Therapeutics market cap is 8.10M.
What Is Inhibitor Therapeutics's Earnings Per Share (TTM)?
The Inhibitor Therapeutics EPS (TTM) is -0.02.
From a Technical Analysis Perspective, Is INTI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Inhibitor Therapeutics Stock Split?
Inhibitor Therapeutics has split 0 times.
How Many Employees Does Inhibitor Therapeutics Have?
Inhibitor Therapeutics has 6 employees.
What is the current trading status of Inhibitor Therapeutics (INTI)?
As of 08 Aug 2025, Inhibitor Therapeutics (INTI) is trading at a price of 0.05, with a previous close of 0.05. The stock has fluctuated within a day range of 0.04 to 0.05, while its 52-week range spans from 0.03 to 0.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.